Economic burden of cardiovascular diseases in the enlarged European Union.

@article{Leal2006EconomicBO,
  title={Economic burden of cardiovascular diseases in the enlarged European Union.},
  author={Jos{\'e} Leal and Ramon Luengo-Fernandez and Alastair Gray and S Petersen and Mike Rayner},
  journal={European heart journal},
  year={2006},
  volume={27 13},
  pages={
          1610-9
        }
}
AIMS Cardiovascular disease (CVD), together with its main components, coronary heart disease (CHD), and cerebrovascular diseases, is the main source of morbidity and mortality in the European Union (EU), but to date, there has not been any systematic cost-of-illness study to assess the economic impact of CVD in the EU. METHODS AND RESULTS CVD-related expenditure was estimated using aggregate data on morbidity, mortality, and healthcare resource use. Healthcare costs were estimated from… 

Figures and Tables from this paper

Economic Burden of Cardiovascular Diseases in the Russian Federation.
Economic burden of cardiovascular diseases in Serbia.
TLDR
The results of the study would be valuable to health policy makers to bridge the gap between invested resources and needs, in order to improve cardiovascular disease outcomes.
Atherosclerotic Cardiovascular Diseases in Belgium: A Cost-of-illness Analysis
TLDR
Atherosclerotic cardiovascular diseases impose a significant economic burden on Belgian society and need to be considered as a public health crisis.
Atherosclerosis: The cost of illness in Portugal.
ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016
TLDR
The economic burden of cardiovascular diseases (CVD) in the Russian Federation in 2016, including the direct costs and the economic losses caused by reduced productivity, reached 2.7 trillion ₽, which is equivalent of 3.2% of GDP for this year.
How much does Europe invest in the treatment of cardiovascular diseases?
TLDR
It is interesting to note that, so far, no systematic evaluation of the economic impact of CVD in Europe has been available.
The Socioeconomic Burden of Coronary Heart Disease in Korea
TLDR
The findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea.
The Grand Challenge of Cardiovascular Epidemiology: Turning the Tide
TLDR
Although efforts to decrease cholesterol levels and smoking have been successful in the United States and Europe over the past two decades, the authors now see increasing prevalences of obesity and type 2 diabetes, and the CVD incidence is now rising rapidly in developing countries as a result of adaptation to a westernized lifestyle.
Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups
TLDR
The magnitude of the relative productivity costs of CVD mortality across a range of disease types and socioeconomic groups highlights the scope for investments in effective healthcare interventions to provide positive economic returns and may assist decision makers in allocating resources among competing priorities.
Full health coverage improves compliance of 50%.
TLDR
The pivotal role of compliance to attain an effective control of cardiovascular risks in clinical practice is confirmed and a low socioeconomic status reduces both drug access and adherence of the patients to physician’s prescriptions is documented.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 46 REFERENCES
The economic burden of coronary heart disease in the UK
TLDR
Coronary heart disease is a leading public health problem in the UK in terms of the economic burden from disease and cost estimates would be substantially understated if informal care/productivity costs were excluded.
Does prevention of cardiovascular diseases lead to decreased cost of illness? Twenty years of experience from Finland.
TLDR
The costs of cardiovascular disease decreased since 1972, however, total costs declined clearly less than the cardiovascular disease mortality rate, implying that considerable savings in total costs, especially in direct health care costs, may not be expected as a result of even very successful prevention programs.
The Costs of Diabetes
TLDR
In the war against diabetes, preventing the occurrence of chronic diabetic complications or diabetes itself seems to be the most efficient and effective way to reduce the great burden of diabetes.
The relation between funding by the National Institutes of Health and the burden of disease.
TLDR
A cross-sectional study comparing estimates of disease-specific funding in 1996 with data on six measures of the burden of disease found that the acquired immunodeficiency syndrome, breast cancer, diabetes mellitus, and dementia all received relatively generous funding, regardless of which measure was used as the basis for calculating support.
The hospital cost of vertebral fractures in the EU: estimates using national datasets
TLDR
The purpose of this study was to estimate the hospital cost of vertebral fractures in the EU using national datasets to explore some of the methodologic limitations associated with such an approach, and found a positive correlation between health expenditure per capita and hospitalization rates was found.
Cost of Stroke in Australia From a Societal Perspective: Results From the North East Melbourne Stroke Incidence Study (NEMESIS)
TLDR
Hospital and nursing home costs contributed most to the total cost of stroke (excluding SAH) in Australia for 1997, and investigation of the cost-effectiveness of rehabilitation services should become a priority in this community.
Towards a new approach for estimating indirect costs of disease.
Cost Minimization Analysis of Antiepileptic Drugs in Newly Diagnosed Epilepsy in 12 European Countries
TLDR
The present analysis investigated the costs of treatment with LTG, CBZ, PHT, and VPA in 12 European countries and found that LTG was twofold to threefold more expensive than the other drugs considered.
Unit costs in international economic evaluations: resource costing of the Schizophrenia Outpatient Health Outcomes Study
Objective:  We present unit costs corresponding to resource information collected in the Schizophrenia Outpatient Health Outcomes (SOHO) Study.
WHO Regional Office for Europe
...
1
2
3
4
5
...